Company: SCLXW
Filing Date: 2025-08-04
Form Type: S-1
Source: 0001193125-25-172703
Chunk: 3

Company: Scilex Holding Co
Filing Date: 2025-08-04
Form: S-1
Chunk 3
---
 Resale Shares does not mean that the Selling Stockholder will offer or sell any of the Resale Shares. If the 1,390,443 Resale Shares offered by the Selling Stockholder under this prospectus were issued and outstanding as of the date hereof, such Resale Shares would represent, as of the date hereof, approximately 16.7% of the total number of shares of our Common Stock outstanding as of July 31, 2025, and approximately 24.7% of the total number of outstanding shares of our Common Stock held by non-affiliates as of July 31, 2025. Any Resale Shares resold hereunder will have been issued by us and acquired by the Selling Stockholder prior to such resale.

The Selling Stockholder is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities Act”). The Selling Stockholder will pay or assume discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar expenses, if any, incurred for the sale of the Resale Shares. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred in registering the Resale Shares, including legal and accounting fees. No placement agent participated in this offering. See the section of this prospectus titled “Plan of Distribution” for additional information. We will bear all costs, expenses and fees in connection with the registration of the shares of our Common Stock hereunder. The Selling Stockholder will bear all commissions and discounts, if any, attributable to its sales of the Resale Shares.

Our Common Stock is listed on the Nasdaq Capital Market under the symbol “SCLX”. On August 1, 2025, the last reported sales price per share of our Common Stock was $13.41.

On April 15, 2025, we effected a reverse stock split of our Common Stock at a ratio of 1-for-35 (the “Reverse Stock Split”). Unless otherwise noted, the share and per share information in this prospectus reflects the effect of the Reverse Stock Split.

We are an “emerging growth company” as that term is used in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings with the Securities and Exchange Commission.

We may amend or supplement this prospectus from